Literature DB >> 19299690

Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice.

Julie A Urban1, William Brugmann, Susan Winandy.   

Abstract

Positive selection is a critical T cell developmental checkpoint that is driven by TCR signals. Enhanced positive selection toward the CD4 lineage occurs in the absence of Ikaros. One explanation for this phenotype is that Ikaros establishes the TCR signaling threshold that must be overcome for positive selection to occur. In the current study, this possibility is explored through the use of CD3zeta ITAM transgenic mice that express a CD3 zeta-chain with zero, one, or three ITAMs and an MHC class II (DO11.10)- or MHC class I (H-Y)-restricted TCR transgene. Using this system, we demonstrate that in the absence of Ikaros, thymocytes are able to mature into the CD4 lineage with reduced TCR signaling potential compared with that required to drive the maturation of wild-type thymocytes. We also demonstrate that maturation into the CD8 lineage is enhanced under conditions of reduced TCR signaling potential in the absence of Ikaros.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299690      PMCID: PMC2777666          DOI: 10.4049/jimmunol.0802869

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection.

Authors:  C Verschelde; D Michonneau; M-C Trescol-Biemont; I Berberich; A Schimpl; N Bonnefoy-Berard
Journal:  Cell Death Differ       Date:  2005-11-18       Impact factor: 15.828

2.  T cell development in mice that lack the zeta chain of the T cell antigen receptor complex.

Authors:  P E Love; E W Shores; M D Johnson; M L Tremblay; E J Lee; A Grinberg; S P Huang; A Singer; H Westphal
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

Review 3.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  BCL-XL-regulated apoptosis in T cell development.

Authors:  D T Chao; S J Korsmeyer
Journal:  Int Immunol       Date:  1997-09       Impact factor: 4.823

5.  Ikaros sets thresholds for T cell activation and regulates chromosome propagation.

Authors:  N Avitahl; S Winandy; C Friedrich; B Jones; Y Ge; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

6.  Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation.

Authors:  J H Wang; A Nichogiannopoulou; L Wu; L Sun; A H Sharpe; M Bigby; K Georgopoulos
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

7.  Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.

Authors:  Alexis Dumortier; Robin Jeannet; Peggy Kirstetter; Eva Kleinmann; MacLean Sellars; Nuno R dos Santos; Christelle Thibault; Jochen Barths; Jacques Ghysdael; Jennifer A Punt; Philippe Kastner; Susan Chan
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 8.  TCR and Notch signaling in CD4 and CD8 T-cell development.

Authors:  Karen Laky; Christine Fleischacker; B J Fowlkes
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

9.  Role of TCR zeta chain in T cell development and selection.

Authors:  E W Shores; K Huang; T Tran; E Lee; A Grinberg; P E Love
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

10.  Role of the multiple T cell receptor (TCR)-zeta chain signaling motifs in selection of the T cell repertoire.

Authors:  E W Shores; T Tran; A Grinberg; C L Sommers; H Shen; P E Love
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  2 in total

1.  Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus.

Authors:  Kevin W Tinsley; Changwan Hong; Megan A Luckey; Joo-Young Park; Grace Y Kim; Hee-Won Yoon; Hilary R Keller; Andrew J Sacks; Lionel Feigenbaum; Jung-Hyun Park
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

2.  Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.

Authors:  Nadine Nelson; Karoly Szekeres; Cristina Iclozan; Ivannie Ortiz Rivera; Andrew McGill; Gbemisola Johnson; Onyekachi Nwogu; Tomar Ghansah
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.